Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.

Literature DB >> 533584

Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.

G Levy.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1979 PMID： 533584 PMCID： PMC1429903 DOI： 10.1111/j.1365-2125.1979.tb01055.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

2 in total

1. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

Authors: D J Tocco; G O Breault; A G Zacchei; S L Steelman; C V Perrier
Journal: Drug Metab Dispos Date: 1975 Nov-Dec Impact factor: 3.922

2. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

Authors: R Verbeeck; T B Tjandramaga; A Mullie; R Verbesselt; R Verberckmoes; P J de Schepper
Journal: Br J Clin Pharmacol Date: 1979-03 Impact factor: 4.335

2 in total

10 in total

1. Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.

Authors: R K Verbeeck; T B Tjandramaga; P J De Schepper; R Verberckmoes
Journal: Br J Clin Pharmacol Date: 1981-11 Impact factor: 4.335

Review 2. Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors: R K Verbeeck; R A Branch; G R Wilkinson
Journal: Clin Pharmacokinet Date: 1981 Sep-Oct Impact factor: 6.447

3. Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

Authors: E M Faed
Journal: Br J Clin Pharmacol Date: 1980-08 Impact factor: 4.335

4. Diflunisal and its conjugates in patients with renal failure.

Authors: R G Dickinson; R K Verbeeck; A R King; A C Restifo; S M Pond
Journal: Br J Clin Pharmacol Date: 1991-05 Impact factor: 4.335

5. Metabolism of amitriptyline in patients with chronic renal failure.

Authors: M Sandoz; S Vandel; B Vandel; B Bonin; B Hory; Y St Hillier; R Volmat
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953

Review 6. Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.

Authors: R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal: Drugs Date: 1980-02 Impact factor: 9.546

Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.

1. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

2. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

1. Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.

Review 2. Drug metabolites in renal failure: pharmacokinetic and clinical implications.

3. Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

4. Diflunisal and its conjugates in patients with renal failure.

5. Metabolism of amitriptyline in patients with chronic renal failure.

Review 6. Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.

7. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.

8. Pharmacokinetic profile of indoprofen in elderly subjects.

Review 9. Clinical pharmacokinetics of ketorolac tromethamine.

10. Biliary excretion of diflunisal conjugates in patients with T-tube drainage.